Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease

ABSTRACT Background and Objective Alpha‐synuclein (α‐Syn) is immunohistochemically detectable in enteric neurons in some subjects. We determined its age distribution in the general autopsy population and in an age‐matched subset investigated differences with Parkinson's (PD) and Alzheimer'...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 28; no. 2; pp. 237 - 241
Main Authors Gold, Andrea, Turkalp, Zorbey T., Munoz, David G.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.02.2013
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Background and Objective Alpha‐synuclein (α‐Syn) is immunohistochemically detectable in enteric neurons in some subjects. We determined its age distribution in the general autopsy population and in an age‐matched subset investigated differences with Parkinson's (PD) and Alzheimer's diseases (AD). Methods Archival autopsy samples of colon from 95 cases (77 general population, 10 PD, and 8 AD) were immunostained with monoclonal antibody KM51. α‐Syn detectability was semiquantitatively graded 1 to 3. Results α‐Syn was detectable in 52% of the general population, and its level of expression did not change between ages 40 and 91. All PD subjects were α‐Syn positive, with higher prevalence (P = 0.001) and grade (P = 0.003) than age‐matched controls. AD subjects were no more likely to be α‐Syn positive or have a higher grade than controls. Conclusions Either PD develops selectively in the enterically α‐Syn‐positive population subset or PD induces this expression. Absence of increased α‐Syn expression in AD points to differences in pathogenesis. © 2013 Movement Disorder Society
Bibliography:ark:/67375/WNG-QS5HGMN9-P
istex:ECB885A980B44E5E53A297F492BEB3B7E6F86B64
ArticleID:MDS25298
Full financial disclosures and author roles may be found in the online version of this article.
Dr. Munoz has received speaker honoraria from Novartis and Janssen, not related to the research reported here.
Relevant Conflicts of Interest/Financial Disclosures
Funding agencies
This study was funded by the Department of Laboratory Medicine at St. Michael's Hospital (Toronto, Ontario, Canada).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0885-3185
1531-8257
1531-8257
DOI:10.1002/mds.25298